# Nuclide record osprey (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/osprey/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "osprey", "NCT02981368" ;
  schema:name "OSPREY"@en ;
  schema:alternateName "18F-DCFPyL staging and recurrence trial"@en ;
  schema:description "An earlier study of the same PSMA PET scan later branded Pylarify, testing how well it detects lymph node spread before surgery in high-risk prostate cancer, and how well it confirms recurrent or spreading disease when a biopsy is possible."@en ;
  schema:url <https://nuclide.cc/trials/osprey/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/33634707/>, <https://clinicaltrials.gov/study/NCT02981368> ;
  nuclide:status "completed" ;
  nuclide:tag "diagnostic trial", "prostate cancer", "staging" ;
  nuclide:phase "2/3" ;
  nuclide:related <https://nuclide.cc/drugs/pylarify/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/indications/prostate-high-risk/>, <https://nuclide.cc/trials/condor/>, <https://nuclide.cc/isotopes/f-18/> .
